[Ovid] A Phase 1, Multiple-dose Study of Elezanumab (ABT-555) in Patients with Relapsing Forms of Multiple Sclerosis (S56.001)

Closed

rafidi Post time 2024-5-27 02:26:52 | Show all posts |Read mode

Reward10points

journal：Neurology

Authors：Adam Ziemann; Matthew Rosebraugh; Bruce Barger; Bruce Cree

Published date：2019-4-9

DOI：10.1212/wnl.92.15_supplement.s56.001

Article link：http://dx.doi.org/10.1212/wnl.92.15_supplement.s56.001

Article Source：Ovid Technologies (Wolters Kluwer Health)。

Remark：

You can support us by donating, we would be very grateful.

Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

rafidi Lv.4

Senior Member

post
reply
points
520

[Ovid] A Phase 1, Multiple-dose Study of Elezanumab (ABT-555) in Patients with Relapsing Forms of Multiple Sclerosis (S56.001) Copy

Reply

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Ovid] A Phase 1, Multiple-dose Study of Elezanumab (ABT-555) in Patients with Relapsing Forms of Multiple Sclerosis (S56.001)